rs587778920

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PM4_Supporting

The NM_000249.4(MLH1):​c.1500_1502del​(p.Ile501del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.00000434 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (β˜…β˜…).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

MLH1
NM_000249.4 inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:9

Conservation

PhyloP100: 6.20
Variant links:
Genes affected
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_000249.4. Strenght limited to Supporting due to length of the change: 1aa.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MLH1NM_000249.4 linkuse as main transcriptc.1500_1502del p.Ile501del inframe_deletion 13/19 ENST00000231790.8 NP_000240.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MLH1ENST00000231790.8 linkuse as main transcriptc.1500_1502del p.Ile501del inframe_deletion 13/191 NM_000249.4 ENSP00000231790 P1P40692-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152172
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000119
AC:
3
AN:
251478
Hom.:
0
AF XY:
0.00000736
AC XY:
1
AN XY:
135906
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000342
AC:
5
AN:
1461882
Hom.:
0
AF XY:
0.00000138
AC XY:
1
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000894
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152172
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74334
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Colorectal cancer, hereditary nonpolyposis, type 2 Pathogenic:1Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Pathogenic, flagged submissionclinical testingCenter for Human Genetics, Inc, Center for Human Genetics, IncNov 01, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJan 26, 2024- -
Hereditary cancer-predisposing syndrome Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthNov 13, 2019This variant causes an in-frame deletion of 1 amino acid of the MLH1 protein. Splice site prediction tools suggest that this variant may not impact RNA splicing. Functional studies showed that this variant protein have wild-type expression level and DNA mismatch repair activity (PMID 29520894). This variant has been reported in 1 individual affected with Lynch Syndrome (PMID 29520894, 28874130). This variant has been identified in 3/251478 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submittercurationSema4, Sema4Jan 13, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 14, 2024The c.1500_1502delCAT variant (also known as p.I501del) is located in coding exon 13 of the MLH1 gene. This variant results from an in-frame CAT deletion at nucleotide positions 1500 to 1502. This results in the in-frame deletion of an isoleucine at codon 501. This alteration has been reported in a Brazilian female with colorectal cancer at age 60 (Rossi BM et al. Ann Surg Oncol, 2002 Jul;9:555-61). This alteration was identified in an individual diagnosed with an adrenocortical tumor who also carries a TP53 mutation, Arg337His (Brondani VB et al. Cancers (Basel), 2020 Mar;12). This alteration was also detected once in a cohort of 1663 Brazilian breast cancer patients who underwent hereditary multigene panel testing (Guindalini RSC et al. Sci Rep, 2022 Mar;12:4190). Of note, this alteration is also designated as c.1499_1501delTCA in published literature. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 06, 2023In-frame deletion of 1 amino acids in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Located in the critical region of interaction with EXO1 and PMS2/MLH2/PMS1 (Plotz et al., 2003; Kosinski et al., 2010; Andersen et al., 2012); Published functional studies demonstrate no damaging effect: no significant effect on protein expression levels or mismatch repair activity (Kger et al., 2018); Observed in individuals with colorectal cancer or breast cancer, and co-observed with a pathogenic TP53 variant in a pediatric patient with adrenocortical neoplasm (Rossi et al., 2002; Brondani et al., 2020; Guindalini et al., 2022); This variant is associated with the following publications: (PMID: 24344984, 12095971, 28874130, 22753075, 12799449, 20533529, 35264596, 29520894, 32156018) -
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMay 15, 2017- -
Lynch syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthApr 27, 2023This variant causes an in-frame deletion of 1 amino acid of the MLH1 protein. Splice site prediction tools suggest that this variant may not impact RNA splicing. Functional studies showed that this variant protein have wild-type expression level and DNA mismatch repair activity (PMID 29520894). This variant has been reported in 1 individual affected with Lynch Syndrome (PMID 29520894, 28874130). This variant has been identified in 3/251478 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024This variant, c.1500_1502del, results in the deletion of 1 amino acid(s) of the MLH1 protein (p.Ile501del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs753409799, gnomAD 0.006%). This variant has been observed in individual(s) with an adrenocortical tumor and/or Lynch syndrome (PMID: 12095971, 28874130, 29520894, 32156018). This variant is also known as c.1499-1501delTCA. ClinVar contains an entry for this variant (Variation ID: 89755). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587778920; hg19: chr3-37070362; API